PND155 - REDUCED RELAPSE RATES AND IMPROVED QUALITY OF LIFE FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS TREATED WITH NATALIZUMAB VS INJECTABLE THERAPIES

Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2903
https://www.valueinhealthjournal.com/article/S1098-3015(18)36278-8/fulltext
Section Title :
Section Order : 1465
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)36278-8&doi=10.1016/j.jval.2018.09.2903
HEOR Topics :
Tags :
Regions :